Hangzhou Alltest plans to distribute over 78.3 million yuan in mid-2025

Hangzhou Alltest Biotechnology Co., Ltd. announced its mid-term profit distribution plan for 2025, proposing to distribute a cash dividend of 10 yuan for every 10 shares to all shareholders, without increasing the share capital or issuing bonus shares. As of the announcement date, the total share capital is 79,280,855 shares, and after deducting the shares held in the repurchase special securities account, the number of shares participating in the distribution is 78,307,224 shares, with a proposed cash dividend of 78,307,224 yuan, accounting for 59.32% of the net profit for the first half of 2025. This plan has been approved by the board of directors and the supervisory board, and according to the authorization of the 2024 annual general meeting of shareholders, it does not need to be submitted for shareholder meeting review and will not have a significant impact on the company's operating cash flow